These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 26519764

  • 1. Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan.
    Wang LJ, Shyu YC, Yuan SS, Yang CJ, Yang KC, Lee TL, Lee SY.
    J Psychiatr Res; 2016 Jan; 72():6-14. PubMed ID: 26519764
    [Abstract] [Full Text] [Related]

  • 2. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
    Shyu YC, Yuan SS, Lee SY, Yang CJ, Yang KC, Lee TL, Wang LJ.
    Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
    [Abstract] [Full Text] [Related]

  • 3. Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan.
    Lee MJ, Yang KC, Shyu YC, Yuan SS, Yang CJ, Lee SY, Lee TL, Wang LJ.
    J Affect Disord; 2016 Jan 01; 189():110-7. PubMed ID: 26433758
    [Abstract] [Full Text] [Related]

  • 4. Impact of negative media publicity on attention-deficit/hyperactivity disorder medication in Taiwan.
    Wang LJ, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Shyu YC.
    Pharmacoepidemiol Drug Saf; 2016 Jan 01; 25(1):45-53. PubMed ID: 26549311
    [Abstract] [Full Text] [Related]

  • 5. The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.
    Perugi G, Vannucchi G.
    Expert Opin Pharmacother; 2015 Jan 01; 16(14):2193-204. PubMed ID: 26364896
    [Abstract] [Full Text] [Related]

  • 6. Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
    Shyu YC, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Wang LJ.
    Clin Ther; 2016 Mar 01; 38(3):595-602. PubMed ID: 26874787
    [Abstract] [Full Text] [Related]

  • 7. Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011.
    Wang LJ, Lee SY, Yuan SS, Yang CJ, Yang KC, Huang TS, Chou WJ, Chou MC, Lee MJ, Lee TL, Shyu YC.
    Epidemiol Psychiatr Sci; 2017 Dec 01; 26(6):624-634. PubMed ID: 27435692
    [Abstract] [Full Text] [Related]

  • 8. Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder.
    Ozbaran B, Kose S, Yuzuguldu O, Atar B, Aydin C.
    World J Biol Psychiatry; 2015 Dec 01; 16(8):619-24. PubMed ID: 26223958
    [Abstract] [Full Text] [Related]

  • 9. A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders.
    Pouchon A, Nasserdine R, Dondé C, Bertrand A, Polosan M, Bioulac S.
    Expert Opin Pharmacother; 2023 Dec 01; 24(13):1497-1509. PubMed ID: 37300473
    [Abstract] [Full Text] [Related]

  • 10. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
    Cortese S, Panei P, Arcieri R, Germinario EA, Capuano A, Margari L, Chiarotti F, Curatolo P.
    CNS Drugs; 2015 Dec 01; 29(10):865-77. PubMed ID: 26293742
    [Abstract] [Full Text] [Related]

  • 11. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY, Pan YL, Lin HY, Huang LW, Gau SS.
    J Child Adolesc Psychopharmacol; 2015 Sep 01; 25(7):566-73. PubMed ID: 26222447
    [Abstract] [Full Text] [Related]

  • 12. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Jerrell JM, McIntyre RS, Park YM.
    J Clin Psychiatry; 2014 Nov 01; 75(11):e1278-83. PubMed ID: 25470092
    [Abstract] [Full Text] [Related]

  • 13. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Jaworowski S, Benarroch F, Gross-Tsur V.
    J Child Adolesc Psychopharmacol; 2006 Jun 01; 16(3):365-70. PubMed ID: 16768644
    [Abstract] [Full Text] [Related]

  • 14. Prescribing patterns for attention deficit hyperactivity disorder among children and adolescents in Taiwan from 2004 to 2017.
    Liao HC, Lin FJ, Hsu CN, Gau SS, Wang CC.
    J Formos Med Assoc; 2023 Jun 01; 122(6):514-517. PubMed ID: 36931958
    [Abstract] [Full Text] [Related]

  • 15. Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan.
    Wang LJ, Yang KC, Lee SY, Yang CJ, Huang TS, Lee TL, Yuan SS, Shyu YC.
    PLoS One; 2016 Jun 01; 11(8):e0161061. PubMed ID: 27518196
    [Abstract] [Full Text] [Related]

  • 16. Attention-Deficit/Hyperactivity Disorder, Its Pharmacotherapy, and Adrenal Gland Dysfunction: A Nationwide Population-Based Study in Taiwan.
    Peng PH, Tsai MY, Lee SY, Liao PC, Shyu YC, Wang LJ.
    Int J Environ Res Public Health; 2020 May 25; 17(10):. PubMed ID: 32466107
    [Abstract] [Full Text] [Related]

  • 17. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY, Hwang JW, Kwak YS, Joung YS, Lee S, Kim B, Sohn SH, Chung US, Yang J, Hong M, Bahn GH, Choi HY, Oh IH, Lee YJ.
    J Korean Med Sci; 2016 Aug 25; 31(8):1284-91. PubMed ID: 27478341
    [Abstract] [Full Text] [Related]

  • 18. Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder.
    Findling RL, Short EJ, McNamara NK, Demeter CA, Stansbrey RJ, Gracious BL, Whipkey R, Manos MJ, Calabrese JR.
    J Am Acad Child Adolesc Psychiatry; 2007 Nov 25; 46(11):1445-53. PubMed ID: 18049294
    [Abstract] [Full Text] [Related]

  • 19. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I, Lee MS, Lee EK, Shin JY.
    Asia Pac Psychiatry; 2018 Mar 25; 10(1):. PubMed ID: 28631372
    [Abstract] [Full Text] [Related]

  • 20. Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study.
    Chou TL, Chia S, Shang CY, Gau SS.
    Eur Neuropsychopharmacol; 2015 Dec 25; 25(12):2300-10. PubMed ID: 26409297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.